Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial

Business Wire December 8, 2014

Research and Markets: Asia-Pacific Advanced Wound Management Market Outlook to 2020: Key players covered include 3M Health Care, Smith & Nephew and ConvaTec

Business Wire December 8, 2014

Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016

GlobeNewswire December 8, 2014

Cancer Genetics, Inc. Announces Launch of Targeted Next Generation Sequencing Based Panel for Chronic Lymphocytic Leukemia, Focus::CLL

GlobeNewswire December 8, 2014

Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence Clinical Trials of ADXS-PSA in Combination With Merck's KEYTRUDA(R) (pembrolizumab) for Prostate Cancer

GlobeNewswire December 8, 2014

NeoStem's Subsidiary, Progenitor Cell Therapy, Earns AABB Re-Accreditation for Its Allendale, NJ Manufacturing Facility

GlobeNewswire December 8, 2014

Applied DNA Sciences Schedules Fiscal Fourth Quarter and Year-End 2014 Webcast for December 16, 2014 at 9:00 AM EST

Marketwired December 8, 2014

Spark Therapeutics Announces Gene Therapy Collaboration in Hemophilia B with Pfizer Inc.

PR Newswire December 8, 2014

Research and Markets: BRIC Digital Wound Measurement Devices Market Outlook to 2020: Key players covered include ARANZ Medical Limited

Business Wire December 8, 2014

Research and Markets: BRIC Gynecological Devices Market Outlook to 2020: Key players covered include Bayer, Hologic, Boston Scientific, Microsulis, Cook and Merit

Business Wire December 8, 2014

Research and Markets: Asia-Pacific Endoscopy Fluid Management Systems Market Outlook to 2020: Key players covered include Olympus, Stryker and KARL STORZ GmbH & Co

Business Wire December 8, 2014

Research and Markets: Asia-Pacific Esophagoscopes & Gastroscopes Market Outlook to 2020: Key players covered include Olympus, Hoya, Fujifilm and KARL STORZ GmbH & Co

Business Wire December 8, 2014

Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition

GlobeNewswire December 8, 2014

Experts in Leukemia Treatment Support Ongoing Phase 1/2 Study of Actinium's Actimab-A, a Low Intensity Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Ages 60 and Older

Marketwired December 8, 2014

BlackBerry and NantHealth Launch Breakthrough NantOmics Cancer Genome Browser

Marketwired December 8, 2014

Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA

Marketwired December 8, 2014

Capnia Presents CoSense® Data at the 2014 American Society of Hematology Annual Meeting

PR Newswire December 8, 2014

Sangamo BioSciences Presents New Data at American Society of Hematology Meeting Demonstrating Broad Application of ZFN Mediated Genome-Editing Approach to Therapeutics for Hemophilia and Lysosomal Storage Disorders

PR Newswire December 8, 2014

BioLineRx Reports Positive Data from Ongoing Phase 2a Study for AML Treatment at ASH Conference

Business Wire December 8, 2014

Generon Presents the Global Phase II Study Results for F-627 (benegrastim) at the American Society of Hematology 56th Annual Meeting at San Francisco

Business Wire December 8, 2014